AIDS and Behavior

, Volume 17, Issue 5, pp 1626–1631

Cost-Utility Analysis of the Housing and Health Intervention for Homeless and Unstably Housed Persons Living with HIV

  • David R. Holtgrave
  • Richard J. Wolitski
  • Sherri L. Pals
  • Angela Aidala
  • Daniel P. Kidder
  • David Vos
  • Scott Royal
  • Nkemdiri Iruka
  • Kate Briddell
  • Ron Stall
  • Arturo Valdivia Bendixen
Original Paper

Abstract

We present a cost-utility analysis based on data from the Housing and Health (H&H) Study of rental assistance for homeless and unstably housed persons living with HIV in Baltimore, Chicago and Los Angeles. As-treated analyses found favorable associations of housing with HIV viral load, emergency room use, and perceived stress (an outcome that can be quantitatively linked to quality of life). We combined these outcome data with information on intervention costs to estimate the cost-per-quality-adjusted-life-year (QALY) saved. We estimate that the cost-per-QALY-saved by the HIV-related housing services is $62,493. These services compare favorably (in terms of cost-effectiveness) to other well-accepted medical and public health services.

Keywords

HIV Housing Homelessness Prevention Cost-effectiveness 

References

  1. 1.
    Aidala AA, Sumartojo E. Why housing? AIDS Behav. 2007;11(Suppl 6):1–6.PubMedCrossRefGoogle Scholar
  2. 2.
    The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Washington, DC: White House; 2010.Google Scholar
  3. 3.
    UN General Assembly. Universal Declaration of Human Rights. 10 December 1948, 217 A (III).Google Scholar
  4. 4.
    Wolitski RJ, Kidder DP, Pals SL, Royal S, Aidala A, Stall R, Holtgrave DR, Harre D. Housing and Health Study Team. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14(3):493–503.PubMedCrossRefGoogle Scholar
  5. 5.
    Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11(Suppl 6):85–100.PubMedCrossRefGoogle Scholar
  6. 6.
    Wolitski RJ, Kidder DP, Fenton KA. HIV, homelessness, and public health: critical issues and a call for increased action. AIDS Behav. 2007;11(Suppl 6):167–71.PubMedCrossRefGoogle Scholar
  7. 7.
    Larimer ME, Malone DK, Garner MD, Atkins DC, Burlingham B, Lonczak HS, Tanzer K, Ginzler J, Clifasefi SL, Hobson WG, Marlatt GA. Health care and public service use and costs before and after provision of housing for chronically homeless persons with severe alcohol problems. JAMA. 2009;301(13):1349–57.PubMedCrossRefGoogle Scholar
  8. 8.
    Poulin SR, Maguire M, Metraux S, Culhane DP. Service use and costs for persons experiencing chronic homelessness in Philadelphia: a population-based study. Psychiatr Serv. 2010;61(11):1093–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Gilmer TP, Manning WG, Ettner SL. A cost analysis of San Diego County’s REACH program for homeless persons. Psychiatr Serv. 2009;60(4):445–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Sadowski LS, Kee RA, VanderWeele TJ, Buchanan D. Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. JAMA. 2009;301(17):1771–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Buchanan D, Kee R, Sadowski LS, Garcia D. The health impact of supportive housing for HIV positive homeless patients: a randomized controlled trial. Am J Public Health. 2009;99 Suppl3:S675-80.Google Scholar
  12. 12.
    Basu A, Kee R, Buchanan D, Sadowski LS. Comparative cost analysis of housing and case management program for chronically ill homeless adults compared to usual care. Health Serv Res. 2012;47(1 Pt 2):523–43.PubMedCrossRefGoogle Scholar
  13. 13.
    Holtgrave DR, Briddell K, Little E, Bendixen AV, Hooper M, Kidder DP, Wolitski RJ, Harre D, Royal S, Aidala A. Cost and threshold analysis of housing as an HIV prevention intervention. AIDS Behav. 2007;11(Suppl 6):162–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press 1996.Google Scholar
  15. 15.
    Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis. 2007;45(Suppl 4):S248–54.PubMedCrossRefGoogle Scholar
  16. 16.
    Chambers JD, Neumann PJ, Buxton MJ. Does Medicare have an implicit cost-effectiveness threshold? Med Decis Making. 2010;30(4):E14–27.PubMedCrossRefGoogle Scholar
  17. 17.
    Centers for Disease Control and Prevention. HIV cost-effectiveness, 5 Jan 2012. Available at http://www.cdc.gov/hiv/topics/preventionprograms/ce/index.htm. Accessed 17 Jan 2012.
  18. 18.
    Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care. 2008;46(4):349–56.PubMedCrossRefGoogle Scholar
  19. 19.
    Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR III, Moore RD, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006;44(11):990–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Hawk M, Davis D. The effects of a harm reduction housing program on the viral loads of homeless individuals living with HIV/AIDS. AIDS Care. 2011 Nov 22. [Epub ahead of print].Google Scholar
  21. 21.
    Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996 10 (suppl A): S75–82.Google Scholar
  22. 22.
    Weaver KE, Antoni MH, Lechner SC, Durán RE, Penedo F, Fernandez MI, Ironson G, Schneiderman N. Perceived stress mediates the effects of coping on the quality of life of HIV-positive women on highly active antiretroviral therapy. AIDS Behav. 2004;8(2):175–83.PubMedCrossRefGoogle Scholar
  23. 23.
    Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.PubMedCrossRefGoogle Scholar
  24. 24.
    Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapam S, Oskamp S, editors. The social psychology of health: Claremont symposium on applied social psychology. Newbury Park: Sage; 1988. Pages 31-67.Google Scholar
  25. 25.
    Holtgrave DR. Is the Elimination of HIV infection within reach in the United States? lessons from an Epidemiologic Transmission Model. Public Health Rep. 2010;125:372–6.PubMedGoogle Scholar
  26. 26.
    Patrick DL, Erickson P. Preventing disease and promoting health: goals for the nation. In health status and health policy allocating resources to health care. New York: Oxford University Press. 1993 292–312.Google Scholar
  27. 27.
    Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570–85.PubMedCrossRefGoogle Scholar
  28. 28.
    Farnham PG, Sansom SL, Hutchinson AB. How much Should we Pay for a new HIV diagnosis? A Mathematical Model of HIV Screening in US Clinical Settings. Med Decis Making. 2012 Jan 12. [Epub ahead of print].Google Scholar
  29. 29.
    Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res. 2008;8(2):165–78.PubMedCrossRefGoogle Scholar
  30. 30.
    Walensky RP. Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policy. Top HIV Med. 2009;17(4):130–4.PubMedGoogle Scholar
  31. 31.
    Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR III, Sloan CE, Sax PE, Walensky RP. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis. 2009;48(6):806–15.PubMedCrossRefGoogle Scholar
  32. 32.
    Hornberger J, Holodniy M, Robertus K, Winnike M, Gibson E, Verhulst E. A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy. Med Decis Making. 2007;27(6):789–821.PubMedCrossRefGoogle Scholar
  33. 33.
    Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26:893–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • David R. Holtgrave
    • 1
  • Richard J. Wolitski
    • 2
  • Sherri L. Pals
    • 2
  • Angela Aidala
    • 3
  • Daniel P. Kidder
    • 2
  • David Vos
    • 4
  • Scott Royal
    • 5
  • Nkemdiri Iruka
    • 1
  • Kate Briddell
    • 6
  • Ron Stall
    • 7
  • Arturo Valdivia Bendixen
    • 8
  1. 1.Department of Health, Behavior and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  2. 2.Division of HIV/AIDS PreventionCenters for Disease Control and PreventionAtlantaUSA
  3. 3.Mailman School of Public HealthColumbia UniversityNew YorkUSA
  4. 4.Department of Housing and Urban DevelopmentWashingtonUSA
  5. 5.Abt Associates, IncCambridgeUSA
  6. 6.Homeless Services ProgramMayor’s Office of Human Services City of BaltimoreBaltimoreUSA
  7. 7.University of PittsburghPittsburghUSA
  8. 8.AIDS Foundation of ChicagoChicagoUSA

Personalised recommendations